KP timeline
Every KP batch the index holds, newest manufacture date first, with the supplier's declared purity beside the median of the index's independent observations of the same lot.
| Lot | Compound | Manufactured | Quarter | Tests | Independent median | Spread (pp) | COA purity | Divergence (pp) | |
|---|---|---|---|---|---|---|---|---|---|
| KP-2607-H5774 | Retatrutide | 13 Jul 2026 | 2026-Q3 | 7 | 96.46 | 0.83 | 96.09 | -0.37 | |
| KP-2605-C5214 | TB-500 | 21 May 2026 | 2026-Q2 | 1 | 99.61 | n<2 | 99.90 | +0.29 | |
| KP-2605-E6585 | Tirzepatide | 12 May 2026 | 2026-Q2 | 6 | 98.17 | 0.62 | 98.59 | +0.42 | |
| KP-2604-X5990 | Hexarelin | 30 Apr 2026 | 2026-Q2 | 6 | 98.69 | 0.97 | 98.58 | -0.11 | |
| KP-2604-N4863 | Retatrutide | 05 Apr 2026 | 2026-Q2 | 4 | 98.46 | 0.52 | 98.12 | -0.34 | |
| KP-2602-X6001 | Tirzepatide | 22 Feb 2026 | 2026-Q2 | 6 | 98.74 | 0.49 | 99.41 | +0.67 | |
| KP-2601-K5213 | Semaglutide | 05 Jan 2026 | 2026-Q2 | 9 | 98.39 | 1.65 | 98.61 | +0.22 | |
| KP-2512-U5694 | Desmopressin | 31 Dec 2025 | 2026-Q2 | 12 | 98.66 | 0.68 | 98.21 | -0.45 | |
| KP-2512-X4745 | Ipamorelin | 28 Dec 2025 | 2026-Q1 | 3 | 98.68 | 0.40 | 98.63 | -0.05 | |
| KP-2511-J5553 | Semaglutide | 23 Nov 2025 | 2026-Q2 | 5 | 99.93 | 0.16 | 99.90 | -0.03 | |
| KP-2511-W5347 | 5-Amino-1MQ | 22 Nov 2025 | 2026-Q2 | 11 | 99.58 | 0.46 | 99.13 | -0.45 | |
| KP-2511-W5891 | Exenatide | 15 Nov 2025 | 2026-Q1 | 7 | 98.18 | 1.10 | 99.00 | +0.82 | |
| KP-2511-M5901 | BPC-157 | 15 Nov 2025 | 2025-Q4 | 11 | 98.45 | 0.91 | 98.53 | +0.08 | |
| KP-2511-K4818 | Retatrutide | 11 Nov 2025 | 2026-Q1 | 3 | 97.19 | 1.01 | 97.60 | +0.41 | |
| KP-2509-N5703 | KPV | 22 Sep 2025 | 2025-Q4 | 7 | 99.16 | 0.54 | 99.51 | +0.35 | |
| KP-2509-J6037 | Semax | 17 Sep 2025 | 2026-Q1 | 2 | 99.53 | 0.41 | 99.62 | +0.09 | |
| KP-2508-Y5884 | Epitalon | 29 Aug 2025 | 2026-Q1 | 6 | 98.58 | 1.13 | 98.43 | -0.15 | |
| KP-2508-D5212 | N-Acetyl Semax Amide | 20 Aug 2025 | 2025-Q4 | 2 | 99.10 | 0.33 | 98.78 | -0.32 | |
| KP-2508-J5271 | Melanotan II | 09 Aug 2025 | 2025-Q3 | 9 | 98.09 | 0.50 | 98.05 | -0.04 | |
| KP-2506-B5255 | Tirzepatide | 05 Jun 2025 | 2025-Q4 | 12 | 97.77 | 2.15 | 97.82 | +0.05 | |
| KP-2506-L6194 | CJC-1295 with DAC | 03 Jun 2025 | 2025-Q3 | 2 | 99.73 | 0.41 | 99.90 | +0.17 | |
| KP-2505-F5424 | Tirzepatide | 18 May 2025 | 2025-Q4 | 2 | 97.36 | 0.30 | 97.47 | +0.11 | |
| KP-2504-V5402 | Tirzepatide | 11 Apr 2025 | 2025-Q3 | 8 | 98.33 | 0.66 | 98.68 | +0.35 | |
| KP-2503-L5154 | GHRP-6 | 15 Mar 2025 | 2025-Q3 | 4 | 98.49 | 0.18 | 99.21 | +0.72 | |
| KP-2502-H5248 | Semax | 18 Feb 2025 | 2025-Q2 | 10 | 98.83 | 1.03 | 98.77 | -0.06 | |
| KP-2502-E5631 | Liraglutide | 11 Feb 2025 | 2025-Q1 | 3 | 99.62 | 0.69 | 99.63 | +0.01 | |
| KP-2501-V5712 | Sermorelin | 08 Jan 2025 | 2025-Q1 | 6 | 98.58 | 0.88 | 98.74 | +0.16 | |
| KP-2501-G6332 | Pemvidutide | 05 Jan 2025 | 2025-Q1 | 1 | 98.34 | n<2 | 98.20 | -0.14 | |
| KP-2412-H5186 | TB-500 | 21 Dec 2024 | 2025-Q2 | 1 | 99.20 | n<2 | 98.74 | -0.46 | |
| KP-2411-Y5476 | CJC-1295 (no DAC) | 25 Nov 2024 | 2024-Q4 | 5 | 99.14 | 0.95 | 99.06 | -0.08 | |
| KP-2409-N5905 | Ipamorelin | 21 Sep 2024 | 2024-Q4 | 5 | 99.28 | 0.44 | 99.39 | +0.11 | |
| KP-2408-L4573 | MK-677 (Ibutamoren mesylate) | 14 Aug 2024 | 2024-Q3 | 3 | 99.52 | 0.41 | 99.90 | +0.38 | |
| KP-2407-T4788 | Tirzepatide | 29 Jul 2024 | 2024-Q3 | 6 | 97.60 | 2.92 | 97.68 | +0.08 | |
| KP-2407-L4785 | BPC-157 | 27 Jul 2024 | 2024-Q4 | 5 | 98.74 | 0.34 | 99.28 | +0.54 | |
| KP-2407-W5062 | N-Acetyl Semax Amide | 24 Jul 2024 | 2024-Q4 | 2 | 98.34 | 0.03 | 97.80 | -0.54 | |
| KP-2407-V6115 | TB-500 | 23 Jul 2024 | 2024-Q4 | 5 | 99.29 | 0.50 | 99.67 | +0.38 | |
| KP-2406-K5300 | IGF-1 LR3 | 20 Jun 2024 | 2024-Q3 | 7 | 98.07 | 1.45 | 98.49 | +0.42 | |
| KP-2405-H5953 | Selank | 11 May 2024 | 2024-Q3 | 2 | 97.81 | 0.38 | 97.93 | +0.12 | |
| KP-2405-C4939 | Semaglutide | 03 May 2024 | 2024-Q3 | 15 | 98.02 | 1.19 | 98.18 | +0.16 | |
| KP-2312-R5133 | Sermorelin | 20 Dec 2023 | 2024-Q2 | 2 | 99.25 | 0.27 | 99.12 | -0.13 |